# 12. Who controls the supply of COVID-19 vaccines, and why does it matter?

by Öner Tulum, William Lazonick, Ken Jacobson, and Ellen Chappelka                          Nine months after the US Food and Drug Administration (FDA) granted emergency use authorization (EUA) to the first of…

#10. Scaling of COVID vaccine manufacturing: Dose selection, stability, and optimization of mRNA-based COVID vaccines

by Öner Tulum, William Lazonick, and Ken Jacobson                           This is the final installment of a three-part series on the scalability of mRNA vaccine production. The current article focuses…